Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...

See how 2026 ADA guidance broadens CGM use beyond insulin, urges payer coverage, and highlights kids, pregnancy, and older ...

A new AI-enabled “Digital Front Door” is intended to match patients to the right site of care pre-arrival, potentially ...

Optum Health posted $1.3B adjusted earnings and cited dual-eligible value-based care associations with fewer admissions and ...

A study in JAMA Dermatology found that people using an AI tool were more accurate and confident in identifying skin ...

ILD was detected in about half of AAV cases, and one-third had fibrotic ILD, indicating a substantial pulmonary fibrosis ...

Diagnostic delay was common (277/505) and operationalized as ≥1 inpatient or ≥2 outpatient diagnoses for key ATTR-CM ...

With Helio Liver, patients can have the blood test done right in the office, which is much more convenient. This convenience ...

Bispecific antibodies are highly efficacious and have a milder side effect profile than other late-line treatments for ...

In this episode, Long-Term Repigmentation Outcomes and Real-World Use of Ruxolitinib Cream, Dr. Desai explores the following ...

Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 ...

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...